DAVID POPLACK to Acquired Immunodeficiency Syndrome
This is a "connection" page, showing publications DAVID POPLACK has written about Acquired Immunodeficiency Syndrome.
Connection Strength
0.232
-
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection. J Pediatr. 1989 May; 114(5):880-4.
Score: 0.072
-
The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann Intern Med. 1989 Feb 15; 110(4):279-85.
Score: 0.071
-
Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis. 1993 Dec; 168(6):1380-6.
Score: 0.025
-
Antiretroviral drug development and clinical pharmacology. Pediatr Infect Dis J. 1991 Nov; 10(11):849-57.
Score: 0.021
-
High-performance liquid chromatographic method for the analysis of 2',3'-dideoxycytidine in human plasma. J Chromatogr. 1990 Nov 16; 532(2):442-4.
Score: 0.020
-
Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1988 Mar; 32(3):324-6.
Score: 0.017
-
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule. J Clin Oncol. 1995 May; 13(5):1238-41.
Score: 0.007